Drug Type Small molecule drug |
Synonyms OT-730, QLT 091568 |
Target |
Mechanism β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC25H36N2O8 |
InChIKeyANXXSWNMHQHOQC-DJNXLDHESA-N |
CAS Registry870809-51-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma, Open-Angle | Phase 2 | US | 01 Sep 2008 | |
Glaucoma | Phase 2 | - | - | |
Glaucoma | Phase 2 | - | - |